Ignite Creation Date:
2025-12-24 @ 3:45 PM
Ignite Modification Date:
2026-04-17 @ 9:14 PM
Study NCT ID:
NCT04944992
Status:
COMPLETED
Last Update Posted:
2023-11-15
First Post:
2021-06-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Efinopegdutide (MK-6024) in Participants With Nonalcoholic Fatty Liver Disease (NAFLD) (MK-6024-001)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-08-04
Start Date Type:
ACTUAL
Primary Completion Date:
2022-10-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-10-19
Completion Date Type:
ACTUAL
First Submit Date:
2021-06-28
First Submit QC Date:
None
Study First Post Date:
2021-06-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-09-27
Results First Submit QC Date:
None
Results First Post Date:
2023-11-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-25
Last Update Post Date:
2023-11-15
Last Update Post Date Type:
ACTUAL